If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Technical Advisory Board Enhanced

9 Jan 2013 07:00

RNS Number : 1103V
Oxford Advanced Surfaces Group PLC
09 January 2013
 



OXFORD ADVANCED SURFACES GROUP PLC

(AIM: OXA)

 

Technical Advisory Board Enhanced

 

Oxford Advanced Surfaces Group ("OAS") the AIM listed technology developer targeting a number of global markets including consumer and industrial displays, solar panels, eyewear and the electronics and adhesion markets, has today announced a key addition to its Technical Advisory Board ("TAB").

 

From 1 January 2013, Professor Steven Abbott joined Professor Mark Moloney on the OAS TAB. Steven brings with him a wealth of industrial, scientific and commercial knowledge from both research posts and a long commercial career at ICI and MacDermid Autotype, covering all areas of the OAS target markets. He is a Fellow of the Royal Society of Chemistry and an independent consultant to global tier 1 industrial partners.

 

Adrian Meldrum, CEO said:

 

 "We are delighted to welcome Steven to the Advisory Board. He has many years of invaluable experience in the key industries and applications in which we operate and will add significant value to our technical and commercial discussions with prospective users of our technology."

 

Prof Steven Abbott commented:

 

 "I am very excited by the opportunity to work with OAS. Its technology offers a range of innovative solutions to significant problems in the world of manufacturing.."

 

 

Prof Steven Abbott received his Oxford Chemistry D Phil for work carried out at Harvard. His post-doctoral was in the Nobel Prizewinning lab of Jean-Marie Lehn at Strasbourg. He is Visiting Professor at the School of Engineering at the University of Leeds. He has worked many years in the high-tech coating industry and along the way developed a passion for computer models that could give real-world insight to complex scientific issues such as precision coating or polymer/nanoparticle solubilities. He is an independent consultant at Steven Abbott TCNF Ltd where he continues to develop software apps on solubility, surfactancy, adhesion, diffusion and advises internationally on topics as diverse as cosmetic/pharma skin delivery, organic photovoltaics, packaging films and "green" surfactant design.

 

09 January 2013

Enquiries:

 

Oxford Advances Surfaces Group Plc www.oxfordsurfaces.com

Adrian Meldrum, Chief Executive Officer

Philip Spinks, Chief Financial Officer T: 01865 854 807

 

W H Ireland Limited www.wh-ireland.co.uk

John Wakefield / Marc Davies T: 0117 945 3471

 

Lothbury FS Ltd www.lothburyfs.com

Gary Middleton / Michael Padley T: 0203 440 7620

 

 

Editors' Note

 

Oxford Advanced Surfaces Group plc (OAS) is a research-based company that develops and licenses intellectual property and products in the areas of highly reactive chemistry and anti-reflective coatings. The Company's research scientists develop innovative solutions in advanced materials and nano-technology for partners to exploit. The Company's solutions apply to real-world, practical processing and innovation challenges as novel polymer and organic materials are introduced to improve cost, weight, space and performance in new products. Initial applications include advanced adhesion, anti-reflective coatings and particle delivery in markets including conventional and plastic electronics, optics, displays, batteries and solar.

www.oxfordsurfaces.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKFDKOBKDDDK
Date   Source Headline
13th Apr 20167:00 amRNSPreliminary Results
21st Oct 20157:00 amRNSCompletion of Capital Reorganisation
7th Oct 20151:56 pmRNSResult of Court Hearing
29th Sep 20153:33 pmRNSHolding(s) in Company
28th Sep 201510:02 amRNSHolding(s) in Company
16th Sep 20157:00 amRNSChange of Name
15th Sep 20153:32 pmRNSHolding(s) in Company
15th Sep 201510:02 amRNSDirectors' Interest in Shares
15th Sep 201510:01 amRNSDirectorate Changes
15th Sep 201510:00 amRNSCompletion of Placing and Acquisition
11th Sep 201510:00 amRNSApplication for Admission
10th Sep 201511:16 amRNSResult of General Meeting
25th Aug 20155:10 pmRNSHalf Yearly Report
25th Aug 20155:05 pmRNSAcquisition and related matters
7th Jul 20157:00 amRNSChange of Name
30th Jun 201512:10 pmRNSResult of AGM
4th Jun 20158:35 amRNSReplacement: Final Results
4th Jun 20157:00 amRNSDirectorate Change
4th Jun 20157:00 amRNSFinal Results
8th Jan 20155:56 pmRNSHolding(s) in Company
9th Sep 20147:00 amRNSCompletion of investment in subsidiary
29th Aug 20147:00 amRNSHalf Yearly Report
14th Jul 201411:00 amRNSResult of AGM
30th Jun 20147:00 amRNSFirst commercial sale
17th Jun 20147:00 amRNSFinal Results
17th Mar 20147:00 amRNSGraphene Functionalisation Capabilities
3rd Feb 20147:00 amRNSProject Announcement
24th Jan 20147:00 amRNSOAS launches OntoTM Development Pack for customer
18th Nov 20135:43 pmRNSHolding(s) in Company
30th Oct 20137:00 amRNSDirectorate Change
18th Oct 20137:00 amRNSChange to substantial shareholdings
20th Sep 20137:00 amRNSDirectorate Change
28th Aug 20139:40 amRNSHalf Yearly Report
13th Jun 20135:30 pmRNSAGM Statement
1st May 20137:00 amRNSFinal Results
12th Apr 20131:10 pmRNSHolding(s) in Company
13th Mar 20138:42 amRNSHolding(s) in Company
12th Mar 20138:37 amRNSHolding(s) in Company
6th Mar 20134:03 pmRNSHolding(s) in Company
9th Jan 20137:00 amRNSTechnical Advisory Board Enhanced
7th Jan 20134:25 pmRNSHolding(s) in Company
20th Dec 20121:55 pmRNSHolding(s) in Company
5th Dec 20125:33 pmRNSHolding(s) in Company
12th Nov 20128:51 amRNSHolding(s) in Company
3rd Oct 20127:00 amRNSDirectors' Interest in Shares
26th Sep 20127:00 amRNSInterim Statement
24th Sep 20129:58 amRNSHolding(s) in Company
17th Sep 20129:26 amRNSHolding(s) in Company
1st Aug 20127:00 amRNSAppointment of CEO
15th Jun 201212:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.